| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 112.93B | 115.12B | 110.58B | 104.38B | 108.28B | 92.64B |
| Gross Profit | 34.47B | 34.57B | 33.94B | 31.16B | 33.73B | 29.14B |
| EBITDA | 19.99B | 20.38B | 19.06B | 15.71B | 16.89B | 13.52B |
| Net Income | 10.27B | 9.90B | 9.43B | 8.67B | 8.53B | 6.31B |
Balance Sheet | ||||||
| Total Assets | 145.76B | 153.00B | 152.99B | 140.78B | 135.36B | 122.58B |
| Cash, Cash Equivalents and Short-Term Investments | 41.42B | 50.07B | 44.90B | 42.45B | 46.90B | 48.75B |
| Total Debt | 1.95B | 0.00 | 755.00M | 133.00M | 219.00M | 0.00 |
| Total Liabilities | 24.28B | 23.45B | 29.83B | 27.81B | 30.23B | 28.24B |
| Stockholders Equity | 121.48B | 129.55B | 123.15B | 112.97B | 105.13B | 94.34B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.38B | 5.33B | -2.60B | -1.28B | 5.60B |
| Operating Cash Flow | 0.00 | 14.45B | 16.01B | 11.97B | 9.12B | 9.76B |
| Investing Cash Flow | 0.00 | -4.75B | -10.98B | -12.31B | -11.20B | -9.66B |
| Financing Cash Flow | 0.00 | -5.45B | -4.90B | -4.15B | -2.50B | -2.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥326.69B | 5.46 | 9.34% | 4.27% | 0.43% | -23.12% | |
79 Outperform | ¥359.59B | 14.16 | 9.59% | 3.91% | 0.25% | 21.48% | |
78 Outperform | ¥175.98B | 15.59 | ― | 2.84% | 4.10% | 5.25% | |
76 Outperform | ¥446.20B | 17.67 | 6.52% | 1.82% | 2.84% | 65.28% | |
74 Outperform | ¥296.44B | 9.05 | 5.47% | 3.41% | 0.23% | -3.05% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥742.66B | 12.79 | 2.01% | 3.82% | -6.89% | -65.83% |